Peer review reports
From: The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
Original Submission |
9 Jan 2021 |
Submitted |
Original manuscript
|
11 Jun 2021 |
Author responded |
Author comments - Oliver Coen
|
Resubmission - Version 2 |
11 Jun 2021 |
Submitted |
Manuscript version 2
|
Publishing |
14 Jun 2021 |
Editorially accepted |
|
1 Jul 2021 |
Article published |
10.1186/s12885-021-08509-w
|
Learn about peer review